[Antifibrinolytic and antihemorrhagic activity of trans-aminomethyl cyclohexane carboxylic acid (AMCHA). Clinical experience].
D000284:Administration, Oral; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D002986:Clinical Trials as Topic; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy; D006469:Hemoptysis / Q000188:drug therapy; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008551:Melena / Q000188:drug therapy; D008595:Menorrhagia / Q000188:drug therapy; D008744:Methylamines / Q000008:administration & dosage / Q000627:therapeutic use; D008796:Metrorrhagia / Q000188:drug therapy; D008875:Middle Aged; D006472:Oral Hemorrhage / Q000188:drug therapy; D011247:Pregnancy; D012771:Shock, Hemorrhagic / Q000188:drug therapy; D013997:Time Factors; D014592:Uterine Hemorrhage / Q000188:drug therapy
D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids; D008744:Methylamines
Attività antifibrinolitica ed antiemorragica dell'acido trans-aminometil-cicloesano-carbossilico (AMCHA). Esperienza clinica.